Recurrent, Delayed Hemorrhage Associated with Edoxaban after Deep Brain Stimulation Lead Placement

Recurrent, Delayed Hemorrhage Associated with Edoxaban after Deep Brain Stimulation Lead Placement

Factor-Xa inhibitors like edoxaban have been shown to have comparable or superior rates of stroke and systemic embolization prevention to warfarin while exhibiting lower clinically significant bleeding rates. The authors report a case of a man who presented with delayed, recurrent intracranial hemor...

Full description

Bibliographic Details
Main Authors: Walavan Sivakumar, Sarah T. Garber, Lauren E. Schrock, Paul A. House
Format: Article
Language:English
Published: Hindawi Limited 2013-01-01
Series:Case Reports in Neurological Medicine
Online Access:http://dx.doi.org/10.1155/2013/691840
id doaj-ef30dfd219fe4436b7c85b14e1d48330
record_format Article
spelling doaj-ef30dfd219fe4436b7c85b14e1d483302020-11-25T00:08:45ZengHindawi LimitedCase Reports in Neurological Medicine2090-66682090-66762013-01-01201310.1155/2013/691840691840Recurrent, Delayed Hemorrhage Associated with Edoxaban after Deep Brain Stimulation Lead PlacementWalavan Sivakumar0Sarah T. Garber1Lauren E. Schrock2Paul A. House3Department of Neurosurgery, Clinical Neurosciences Center, The University of Utah, Salt Lake City, Utah, UT 84132, USADepartment of Neurosurgery, Clinical Neurosciences Center, The University of Utah, Salt Lake City, Utah, UT 84132, USADepartment of Neurology, Clinical Neurosciences Center, The University of Utah, Salt Lake City, UT 84132, USADepartment of Neurosurgery, Clinical Neurosciences Center, The University of Utah, Salt Lake City, Utah, UT 84132, USAFactor-Xa inhibitors like edoxaban have been shown to have comparable or superior rates of stroke and systemic embolization prevention to warfarin while exhibiting lower clinically significant bleeding rates. The authors report a case of a man who presented with delayed, recurrent intracranial hemorrhage months after successful deep brain stimulator placement for Parkinson disease while on edoxaban for atrial fibrillation. Further reports on the use of novel anticoagulants after intracranial surgery are acutely needed to help assess the true relative risk they pose.http://dx.doi.org/10.1155/2013/691840
collection DOAJ
language English
format Article
sources DOAJ
author Walavan Sivakumar
Sarah T. Garber
Lauren E. Schrock
Paul A. House
spellingShingle Walavan Sivakumar
Sarah T. Garber
Lauren E. Schrock
Paul A. House
Recurrent, Delayed Hemorrhage Associated with Edoxaban after Deep Brain Stimulation Lead Placement
Case Reports in Neurological Medicine
author_facet Walavan Sivakumar
Sarah T. Garber
Lauren E. Schrock
Paul A. House
author_sort Walavan Sivakumar
title Recurrent, Delayed Hemorrhage Associated with Edoxaban after Deep Brain Stimulation Lead Placement
title_short Recurrent, Delayed Hemorrhage Associated with Edoxaban after Deep Brain Stimulation Lead Placement
title_full Recurrent, Delayed Hemorrhage Associated with Edoxaban after Deep Brain Stimulation Lead Placement
title_fullStr Recurrent, Delayed Hemorrhage Associated with Edoxaban after Deep Brain Stimulation Lead Placement
title_full_unstemmed Recurrent, Delayed Hemorrhage Associated with Edoxaban after Deep Brain Stimulation Lead Placement
title_sort recurrent, delayed hemorrhage associated with edoxaban after deep brain stimulation lead placement
publisher Hindawi Limited
series Case Reports in Neurological Medicine
issn 2090-6668
2090-6676
publishDate 2013-01-01
description Factor-Xa inhibitors like edoxaban have been shown to have comparable or superior rates of stroke and systemic embolization prevention to warfarin while exhibiting lower clinically significant bleeding rates. The authors report a case of a man who presented with delayed, recurrent intracranial hemorrhage months after successful deep brain stimulator placement for Parkinson disease while on edoxaban for atrial fibrillation. Further reports on the use of novel anticoagulants after intracranial surgery are acutely needed to help assess the true relative risk they pose.
url http://dx.doi.org/10.1155/2013/691840
work_keys_str_mv AT walavansivakumar recurrentdelayedhemorrhageassociatedwithedoxabanafterdeepbrainstimulationleadplacement
AT sarahtgarber recurrentdelayedhemorrhageassociatedwithedoxabanafterdeepbrainstimulationleadplacement
AT laureneschrock recurrentdelayedhemorrhageassociatedwithedoxabanafterdeepbrainstimulationleadplacement
AT paulahouse recurrentdelayedhemorrhageassociatedwithedoxabanafterdeepbrainstimulationleadplacement
_version_ 1725414782943625216

Similar Items